Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Join LifeNet Health LifeSciences for our first Assay Services webinar, focusing on Dermal Absorption. This session explores in vitro permeation testing, a crucial method for assessing a compound’s potential to penetrate the skin and reach systemic circulation.
Cell-Based Assays for Immuno-oncology
Join Lonza scientist Ethan Shelkey as he explores how cell-based assays can assess immune activation and support immunotherapy development.
The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model
On June 4, 2025, Dr. Martin Stahl led a webinar exploring how cellular composition affects organoid performance in drug response and toxicity assays. He also introduced IntestiCult™ Plus Organoid Growth Medium, a next-generation organoid medium that supports simultaneous expansion and differentiation of intestinal organoids. Below are answers to audience questions from the session, edited for brevity and clarity.
Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection
Learn how AI is advancing preclinical research through quantitative pathology, curated biospecimen data, and intelligent tumor model selection in this expert-led webinar.
Understanding Biological Material Licensing for Preclinical Research
Learn why biological material licensing matters in preclinical research, what risks to avoid, and how to manage licenses for cell lines, organoids, PDX models, and more.
CAR Finder – A Platform for Rapid CAR T Cell Screening
Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection.
CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV
Get practical insight into CRISPR-Cas9 gene editing in primary immune cells and how it can be applied to study drug action in a physiologically relevant model.
Fresh or Cryopreserved Leukopaks? Assessing the Impact of Different Storage Conditions on Leukopak Stability
Join Dr. Wassim Basheer from Charles River Laboratories as he shares impactful data looking at stability of fresh and cryopreserved leukopaks.
The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model
Are you confident that your intestinal organoid models contain the right cell types to generate predictive, reproducible, and translatable results?
Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Improved Clearance Predictions for Aldehyde Oxidase Substrates Using TruVivo, a Novel Human Hepatocyte Model
In this exclusive session, Stephanie Piekos, PhD, Senior Scientist at Boehringer Ingelheim, shares insights into the challenges of evaluating AO substrates and how more predictive, human-relevant models are shaping the future of DMPK studies.
Introduction to Bispecific Antibodies and Their Production
In this webinar, Dr. Brady Wu discusses bispecific antibody drugs and their production.
Integrating Functionalized Multi-omics in Oncology Drug Discovery
Discover how cutting-edge multi-omics approaches and Generative AI are reshaping oncology drug discovery.
Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
Breaking the Bottleneck: Harnessing Proteomics Services to Overcome Challenges in Clinical Research
This webinar will demonstrate how integrating high-plex proteomics services can help overcome barriers, accelerating decision-making throughout drug development.
Discovery and Engineering of High-Affinity Soluble T Cell Receptors via a High-Throughput Yeast-Based Platform
Join Dr. Garrett Rappazzo as he presents his team’s research on the discovery and engineering of soluble T cell receptors for peptide-HLA targeting therapeutics.
Understanding Sex Differences in Stress Response
This study by UF Health reveals sex-specific differences in stress responses linked to the neurosteroid allopregnanolone, offering insights for developing personalized treatments for stress-related disorders.
Towards Eliminating Small Molecule Toxicity: Axiom’s AI Models for Clinical Safety Assessment
Join Axiom’s webinar to explore how AI/ML enhances clinical toxicity assessments, delivering accurate, cost-effective DILI risk predictions at human exposure levels.
High-Quality Mobilized Leukopaks to Enhance Your Cell and Gene Therapy Research and Development
Learn about mobilized leukopaks, CD34+ cell isolation, and cutting-edge techniques in cell and gene therapy research with STEMCELL Technologies.
Considerations in Tissue Acquisition and Characterization for the Development of Long-Term Tumoroid Models
Join experts from Discovery Life Science as they explore cutting-edge 3D tumor models and their potential to accelerate cancer research and development.
Advancing Your Innovation: Navigating the Complexity of Stable Cell Line Development
Join experts from ProteoGenix and Eurofins as they share strategies and solutions to streamline stable cell line development, ensuring high yields, clonal homogeneity, and seamless GMP transitions for biopharmaceutical success.
The Impact of Nutrition on T Cell Fate and Exhaustion
Researchers at the Salk Institute have discovered that a switch from acetate to citrate as a nutritional source significantly influences T cell identity, particularly transforming active effector T cells into exhausted ones in chronic infections like cancer and HIV.
The Complexities and Risks of Microbiome Interventions for Children
Probiotics, touted for their health benefits, are raising FDA safety warnings and concerns about their use in infants, while regulatory challenges similarly impact fecal microbiota transplants (FMT). Consequently, medical professionals urge caution with probiotics and FMT in vulnerable groups, emphasizing potential risks over benefits.
Industry Insights with Bas Trietsch and STEMCELL Technologies
Dr. Bas Trietsch and Dr. Jenna Moccia discuss stem cell-based models and organ-on-a-chip systems in this episode of Industry Insights.
Industry Insights with Bas Trietsch and STEMCELL Technologies
Drs. Jenna Moccia and Bas Trietsch explore how stem cell-based models are transforming drug discovery and preclinical research.
